Patents by Inventor Geralyn Duska-Mcewen

Geralyn Duska-Mcewen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10792294
    Abstract: A method for enhancing an individual's mucosal innate immune response to pathogens is disclosed. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes about 0.05 to about 0.5 mg/mL 2?-fucosyllactose (2?-FL), about 0.05 to about 0.5 mg/mL lacto-N-neotetraose (LNnT), or a combination of both. Also disclosed is a method for enhancing an individual's mucosal innate immune detection of pathogens. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes a neutral human milk oligosaccharide.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: October 6, 2020
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Geralyn Duska-McEwen, Steven Davis
  • Publication number: 20200230162
    Abstract: Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide.
    Type: Application
    Filed: April 2, 2020
    Publication date: July 23, 2020
    Applicant: ABBOTT LABORATORIES
    Inventors: GERALYN DUSKA-MCEWEN, SARAH COMSTOCK, SHARON DONOVAN, RACHAEL BUCK, JOSEPH SCHALLER
  • Patent number: 10624916
    Abstract: Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: April 21, 2020
    Assignee: ABBOTT LABORATORIES
    Inventors: Geralyn Duska-Mcewen, Sarah Comstock, Sharon Donovan, Rachael Buck, Joseph Schaller
  • Publication number: 20170020906
    Abstract: A method for enhancing an individual's mucosal innate immune response to pathogens is disclosed. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes about 0.05 to about 0.5 mg/mL 2?-fucosyllactose (2?-FL), about 0.05 to about 0.5 mg/mL lacto-N-neotetraose (LNnT), or a combination of both. Also disclosed is a method for enhancing an individual's mucosal innate immune detection of pathogens. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes a neutral human milk oligosaccharide.
    Type: Application
    Filed: April 3, 2015
    Publication date: January 26, 2017
    Applicant: ABBOTT LABORATORIES
    Inventors: RACHAEL BUCK, GERALYN DUSKA-MCEWEN, STEVEN DAVIS
  • Publication number: 20160256479
    Abstract: Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide.
    Type: Application
    Filed: December 20, 2013
    Publication date: September 8, 2016
    Applicant: ABBOTT LABORATORIES
    Inventors: GERALYN DUSKA-MCEWEN, SARAH COMSTOCK, SHARON DONOVAN, RACHAEL Buck, JOSEPH SCHALLER
  • Publication number: 20130243904
    Abstract: Disclosed are nutritional products comprising pea protein hydrolysates as a primary or sole source of protein. The nutritional products include nutritional liquids, powders, bars, and other food products, wherein the resulting nutritional products are physically stable over shelf life and provide favorable organoleptic properties. These nutritional products may be used as a nutritional source for individuals who are intolerant and/or allergic to cow milk proteins and soy proteins and/or who have malabsorption, maldigestion, or other gastroinstestinal conditions.
    Type: Application
    Filed: August 22, 2011
    Publication date: September 19, 2013
    Applicant: ABBOTT LABORATORIES
    Inventors: Christopher T. Cordle, Steven T. Luebbers, Larry W. Williams, Jeffrey Harris Baxter, Geralyn Duska-Mcewen